(Q36619766)

15 August 2017

1 reference

title

Management of osteosarcoma (English)

1 reference

15 August 2017

Jeremy Whelan

1

1 reference

15 August 2017

Beatrice Seddon

series ordinal

2

1 reference

15 August 2017

Martha Perisoglou

series ordinal

3

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Current Treatment Options in Oncology

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

6

1 reference

15 August 2017

page(s)

444-455

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-006-0020-y

15 August 2017

exact match

0 references

cites work

Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-006-0020-Y

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases

21 January 2018

1 reference

12 December 2020

Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy

1 reference

12 December 2020

Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement

1 reference

12 December 2020

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

1 reference

12 December 2020

Osteosarcoma and interferon. Studies of human xenografts in the nude mouse

1 reference

12 December 2020

Long-Term Adjuvant Interferon Treatment of Human Osteosarcoma: A pilot study

1 reference

12 December 2020

Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study

1 reference

12 December 2020

Occupational factors and risk of adult bone sarcomas: a multicentric case-control study in Europe

1 reference

12 December 2020

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

1 reference

12 December 2020

Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarter

1 reference

12 December 2020

Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

1 reference

12 December 2020

Clinico-histologic parameters of osteosarcoma patients with late relapse

1 reference

12 December 2020

Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities

1 reference

12 December 2020

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

12 December 2020

The therapy of osteogenic sarcoma: Current status and thoughts for the future

1 reference

12 December 2020

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

1 reference

12 December 2020

Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

1 reference

12 December 2020

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

1 reference

12 December 2020

Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series

1 reference

12 December 2020

Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma.

1 reference

12 December 2020

Amputation and Adriamycin in Primary Osteosarcoma

1 reference

12 December 2020

Radiotherapy for local control of osteosarcoma.

1 reference

12 December 2020

Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide

1 reference

12 December 2020

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

1 reference

12 December 2020

Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute

1 reference

12 December 2020

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group

1 reference

12 December 2020

Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation

1 reference

12 December 2020

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

1 reference

12 December 2020

Late relapse of osteosarcoma: implications for follow-up and screening

1 reference

12 December 2020

Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery

1 reference

12 December 2020

Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response

1 reference

12 December 2020

Preoperative therapy versus immediate surgery in nonmetastatic osteosarcoma.

1 reference

12 December 2020

Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide

1 reference

12 December 2020

Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma

1 reference

12 December 2020

Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells

1 reference

12 December 2020

Is Interferon Tissue Specific? -- Effect of Human Leukocyte and Fibroblast Interferons on the Growth of Lymphoblastoid and Osteosarcoma Cell Lines

1 reference

12 December 2020

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study

1 reference

12 December 2020

Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol

1 reference

12 December 2020

Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration

1 reference

12 December 2020

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

1 reference

12 December 2020

Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview.

1 reference

12 December 2020

Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience

1 reference

12 December 2020

Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.

1 reference

12 December 2020

Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients.

1 reference

12 December 2020

A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma

1 reference

12 December 2020

Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide

1 reference

12 December 2020

National Cancer Data Base report on osteosarcoma of the head and neck.

1 reference

12 December 2020

A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup

1 reference

12 December 2020

Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report

1 reference

12 December 2020

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases

1 reference

12 December 2020

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

1 reference

12 December 2020

Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants

1 reference

12 December 2020

Prospectively planned analysis of data from a phase III study of liposomal muramyltripeptide phosphatidylethanolamine in the treatment of osteosarcoma

1 reference

12 December 2020

The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma

1 reference

12 December 2020

High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma

1 reference

12 December 2020

Effects of leukocyte interferon (E. coli) on human bone sarcoma growth in vitro and in the nude mouse.

1 reference

12 December 2020

Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?

1 reference

12 December 2020

Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)

1 reference

12 December 2020

10.1007/S11864-006-0020-Y

Identifiers

DOI

1 reference

15 August 2017

1 reference